Department of Dermatology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Test Evaluation Research Group, Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, UK.
Br J Cancer. 2021 May;124(11):1749-1750. doi: 10.1038/s41416-021-01302-3. Epub 2021 Mar 19.
Smartphone applications ("apps") with artificial intelligence (AI) algorithms are increasingly used in healthcare. Widespread adoption of these apps must be supported by a robust evidence-base and app manufacturers' claims appropriately regulated. Current CE marking assessment processes inadequately protect the public against the risks created by using smartphone diagnostic apps.
智能手机应用程序(“apps”)带有人工智能(AI)算法,在医疗保健领域的应用越来越多。广泛采用这些应用程序必须建立在强大的证据基础上,并对应用程序制造商的声明进行适当监管。目前的 CE 标志评估程序不能充分保护公众免受使用智能手机诊断应用程序带来的风险。